Tag Archive for: patients
https://pioneerinstitute.org/wp-content/uploads/PBM-photo-09122023.png 1400 1400 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2023-09-11 19:23:322023-09-11 19:23:32Lousy Healthcare for Thee but Not for Me
In recent years, pharmacy benefit managers (PBMs) have instituted programs to keep out-of-pocket drug costs high for patients. Why is the administration so eager to protect federal employees from high out-of-pocket costs but is perfectly happy for PBMs to enroll millions of other patients in these programs?
https://pioneerinstitute.org/wp-content/uploads/Screenshot-2023-06-12-at-10.53.19-AM.png 818 1260 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2023-06-12 10:58:462023-06-12 10:58:46Opinion: Legislature should act on bill to limit out-of-pocket drug costs
S. 609, a bill that would limit out-of-pocket costs for patients paying for prescription drugs, is a clear step in the right direction. Massachusetts should join 16 other states that have passed similar bills to protect patients.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-Direct-Dispense.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-04-18 11:25:122023-05-04 16:27:06Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer Programs
A new white paper, "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Copayment Assistance Programs," examines how the way these programs are implemented is having negative impacts on patients living with serious diseases.
https://pioneerinstitute.org/wp-content/uploads/Direct-Dispense.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-04-06 07:03:212023-05-15 15:41:52Study: Massachusetts Should Join 45 States and Allow Prescribers to Dispense Medications
A Pioneer Institute study shows that middlemen—commercial pharmacies and pharmacy benefit managers—add substantial costs over wholesale prices. Allowing prescribers to dispense routine drugs would save consumers money without compromising safety.
https://pioneerinstitute.org/wp-content/uploads/340-web-post.png 900 1600 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-03-22 05:41:312022-03-25 14:38:00Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes
Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.
https://pioneerinstitute.org/wp-content/uploads/Five-Reasons-Why-Drug-Rebates-Are-Harmful-to-Patients-and-to-the-Healthcare-System-8.png 512 1024 Barbara Anthony https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Barbara Anthony2020-10-28 07:29:142021-12-29 12:07:25Healthcare Price Transparency in Massachusetts: Results from a survey of Massachusetts consumers regarding healthcare price transparency
In June 2019, Pioneer Institute, with support from Blue Cross Blue Shield of Massachusetts and the Massachusetts Association of Health Plans, contracted with noted pollster David Paleologos, head of DAPA Research at Suffolk University’s Research Bureau, to conduct a valid and reliable survey of Massachusetts consumers with employer sponsored health insurance. The goals of the survey were to determine consumers’ awareness, attitudes, views, usage, and knowledge of healthcare prices. This white paper presents analysis of the results.